Tau Kinetics in Neurons and the Human Central Nervous System

Cited by (584)

Items 501–584 of 584

1. Frontotemporal dementia associated CHCHD10V57E mutation aggravates tau pathology via disrupting the CHCHD10-Rab7A-TBC1D15 complex
   Jie Sheng, Jing Yan, Yan Xu, Xingyu Xu, Xuemei Zhang, A G Wang, Buhui Liu, Jun Ma, Xiuying Duan, Heng Zhou et al. · 2026 · Cell Death and Disease
2. Diagnostic accuracy of CSF and plasma pTau-181, pTau-217, and pTau-231 for Alzheimer’s disease: a diagnostic meta-analysis
   Hazem E. Mohammed, Mohamed E. Haseeb, Mohamed Nasser, George Hanen, Mohamed Abdelkader, Hatem Yaser, Shehab Yaser, Ahmed Samir, Yusra Arafeh, Mohamed Wagdy et al. · 2026 · Acta Neurologica Belgica
3. Spatiotemporal characterization of Alzheimer disease pathology in living human brain tissue
   Aram Aslanyan, Soumya Mukherjee, Eleanor M. Moncur, Alicja Szadziewska, Yingxin He, Przemysław Radosław Kac, Reid A. Coyle, Elena Camporesi, Chihiro Sato, Nupur Ghoshal et al. · 2026 · Nature Communications
4. Nursing Intervention for Caregivers of Patients with Alzheimer's Disease regarding Burden of Care
   Zeinab Ibrahim Mahmoud, Howyida Sadek Abd El-Hameed, Doaa Mohamed Sobhy Elsayed · 2022 · Journal of Nursing Science Benha University/Journal of Nursing Science Benha University
5. Evaluation of SP3 for antibody-free quantification of tau in CSF mimic and brain by mass spectrometry
   Chloé Jacquemin, Nicolas Villain, Rita Azevedo, Susana Boluda, Etienne Thévenot, François Fenaille, Foudil Lamari, François Bécher · 2024 · European Journal of Mass Spectrometry
6. Gender-Specific DNA Methylation Profiles Associated with Adult Weight in Hezuo Pigs
   Rui Jia, Xiaoyu Huang, Jiaojiao Yang, Longlong Wang, Jie Li, Yao Li, Shuangbao Gun, Zunqiang Yan, Pengfei Wang, Qiaoli Yang · 2024 · International Journal of Molecular Sciences
7. Faculty Opinions recommendation of The sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF tau in humans.
   Luigi Fontana · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
8. Targeting multiphosphorylated tau: technical and clinical validation of a new Simoa® assay for CSF and plasma detection of tau simultaneously phosphorylated at T181 and T231
   Anna Lidia Wojdała, Giovanni Bellomo, Lorenzo Gaetani, Dandan Shan, Lucilla Parnetti, Davide Chiasserini · 2023 · medRxiv
9. Mass Spectrometry-Based Quantification of Orexin Species in Human Cerebrospinal Fluid Reveals Differential Dynamics Associated with Sleep
   Kanta Horie, Rama K. Koppisetti, Christopher J. Steger, Giuseppe Plazzi, Brendan P. Lucey · 2025 · medRxiv
10. A HaloTag–4R-Tau Pulse-Chase Sensor Reveals Neddylation Inhibition Promotes Degradation of Tau in iNeurons
    Qiang Xiao, Zi Gao, Seth Allen, Danny Garza, Richard I. Morimoto, Jeffery W. Kelly · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
11. Early memory deficits and extensive brain network disorganization in the AppNL-F/MAPT double knock-in mouse model of familial Alzheimer's disease
    Christopher Borcuk · 2021 · theses.fr (ABES)
12. Characterizing the physicochemical properties of TDP-43 protein and Acetylated Amyloid β peptides to discern its role in neurodegenerative diseases
    Rashmi Adhikari · 2019 · Digital Commons - Michigan Tech (Michigan Technological University)
13. University College London/University of Gothenburg PhD course “Biomarkers in neurodegenerative diseases” 2019—course organisation
    Ayesha Khatun, Ross W. Paterson, Michael Schöll · 2020 · Alzheimer s Research & Therapy
14. Tau proteolysis mechanisms and relevance for tauopathies
    James P. Quinn · 2019 · Research Explorer (The University of Manchester)
15. Characterization of Tau ELISAs for Evaluating Tau Accumulation in the Brains With Alzheimer’s Disease
    Mitsuru Shinohara, Junko Hirokawa, Akemi Shimodaira, Yoshitaka Tashiro, Kaoru Suzuki, Akio Fukumori, Tomoyasu Matsubara, Maho Morishima, Yuko Saito, Shigeo Murayama et al. · 2021 · Research Square
16. Microbial Influence on Alzheimer's Disease
    Ashley Hamby · 2021 · The Cardinal Edge
17. Комплексный метод анализа геометрической точности цилиндров в процессе сборки судовых малоразмерных дизелей
    Яхьяев Насреддин Яхьяевич, Nurulla M. Vagabov · 2009 · VESTNIK OF ASTRAKHAN STATE TECHNICAL UNIVERSITY SERIES MARINE ENGINEERING AND TECHNOLOGIES
18. Performance of plasma amyloid, tau, and astrocyte biomarkers to identify cerebral AD pathophysiology
    Pâmela C.L. Ferreira, Cécile Tissot, João Pedro Ferrari‐Souza, Wagner Scheeren Brum, Bruna Bellaver, Douglas Teixeira Leffa, Joseph Therriault, Andréa Lessa Benedet, Firoza Zubeida Lussier, Mira Chamoun et al. · 2022 · medRxiv
19. Exploring the human Hsp70-Hop-Hsp90 system for Tau recognition
    Antonia Moll · 2022 · eDiss (Georg-August-Universität Göttingen)
20. Faculty Opinions recommendation of The sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF tau in humans.
    Ralph E. Mistlberger, Brianne A. Kent · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
21. Faculty Opinions recommendation of The sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF tau in humans.
    Jonathan Kipnis, Sandro Dá Mesquita · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
22. Advantages and limitations of hiPSC-derived neurons for the study of neurodegeneration
    Swati Mishra, Coen Van Deursen, Aiko Robert, Rik van der Kant, Jessica E. Young · 2022 · Elsevier eBooks
23. Serum Tau-A and Tau-C Levels and Their Association with Cognitive Impairment and Dementia Progression in a Memory Clinic Derived Cohort
    Tobias Melton Axelsen, Peter Høgh, Asger Reinstrup Bihlet, M.A. Karsdal, K Henriksen, Steen Gregers Hasselbalch, A H Simonsen · 2024 · The Journal of Prevention of Alzheimer s Disease
24. To move from CSF biomarkers to blood biomarkers
    健作 春日 · 2024 · Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics
25. Additional file 1 of Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
    Pieter Jelle Visser, Lianne Maria Reus, Johan Gobom, Iris E. Jansen, Ellen Dicks, Sven J. van der Lee, Magda Tsolaki, Frans R.J. Verhey, Julius Popp, Pablo Martínez‐Lage et al. · 2022 · Figshare
26. Additional file 2 of Four subgroups based on tau levels in Alzheimer’s disease observed in two independent cohorts
    Flora Hillegonde Duits, Kirsten E. J. Wesenhagen, Laura L. Ekblad, Emma E. Wolters, Eline A.J. Willemse, Philip Scheltens, Wiesje M. van der Flier, Charlotte Elisabeth Teunissen, Pieter Jelle Visser, Betty Marije Tijms · 2021 · Figshare
27. Enabling Population Protein Dynamics Through Bayesian Modeling
    Sylvain Lehmann, Jérôme Vialaret, Audrey Gabelle, Luc Bauchet, Jean-Philippe Villemin, Christophe Hirtz, Jacques Colinge · 2024 · Bioinformatics
28. Exploratory Blood Biomarker Patterns in a Mixed Dementia Cohort
    Haşim Gezegen, Merve Alaylıoğlu, Erdi Şahin, Owen Swann, Elena Veleva, Gamze Güven, Ümran Yaman, Dervis A. M. Salih, Başar Bılgıç, Haşmet Ayhan Hanağası et al. · 2024 · medRxiv
29. Unraveling Alzheimer's disease heterogeneity:
    Eleonora M. Vromen · 2024
30. New Research on Biomarkers in Alzheimer’s Continuum
    Immacolata Vecchio, Carmela Colica · 2025 · Reviews on Recent Clinical Trials
31. A preliminary study on plasma markers across cognitive stages and links to a history of mild traumatic brain injury
    Christian LoBue, Barbara Elena Stopschinski, Nil Saez-Calveras, Amber R. Salter, Douglas R Galasko, Christopher C. Giza, C. Munro Cullum, Peter M. Douglas, John Hart · 2025 · Journal of Alzheimer s Disease
32. Neuron-specific enolase and Tau protein as biomarkers for sepsis-associated delirium: a cross-sectional pilot study
    Agnes Araújo Sardinha Pinto, Maira Mello de Carvalho, J Santos, Rebeca Souza da Silva, Hermes Vieira Barbeiro, Luz Marina Gómez Gómez, Ian Ward Abdalla Maia, Júlio Flávio Meirelles Marchini, Flávia Barreto Garcez, Thiago Junqueira Avelino‐Silva et al. · 2025 · Einstein (São Paulo)
33. Game Design to Diagnose and Improve Cognitive Disorders
    Arad Eskandari Veshareh · 2024 · Journal of Theoretical Physics & Mathematics Research
34. Polyanionic peptibody ameliorates tau pathology and promotes neuronal proteostasis in a tau transgenic mouse model
    Alayna C. Caruso, Tomas Kavanagh, Ashley J. Waardenberg, Mark Evan Graham, Eleanor Drummond, Rebecca M. Nisbet · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
35. The Application of Directly Induced Neurons to Neurodegenerative Disease Research
    Sumihiro Maeda · 2025 · Stem cell biology and regenerative medicine
36. Antimicrobial peptides act as a component of brain immunity against microbes in Alzheimer’s disease
    Madhura Chandrashekar, Gowshika Velmurugan, Amit Mishra, Subashchandrabose Chinnathambi · 2025 · Advances in protein chemistry and structural biology
37. Cerebrospinal Fluid, Molecular Neuroimaging, and Blood Biomarkers of Neurodegenerative Disease: Past, Present, and Future
    David N. Soleimani‐Meigooni, Gil Dan Rabinovici · 2025 · Cambridge University Press eBooks
38. Tau‐targeting active immunotherapy slows progression and reduces pathology in mouse models of tauopathy
    Christopher M. Brown, Jeanne Kaye Brooks, Louise Kelly, Madeline M. Vroom, Matthew Longo, Jean‐Cosme Dodart, Roxana Octavia Carare, Justin D. Boyd · 2025 · Brain Pathology
39. Additional file 1 of Four subgroups based on tau levels in Alzheimer’s disease observed in two independent cohorts
    Flora Hillegonde Duits, Kirsten E. J. Wesenhagen, Laura L. Ekblad, Emma E. Wolters, Willemse, Eline A. J., Philip Scheltens, Wiesje M. van der Flier, Charlotte Elisabeth Teunissen, Pieter Jelle Visser, Betty Marije Tijms · 2021 · Figshare
40. Additional file 1 of Regional correlation of biochemical measures of amyloid and tau phosphorylation in the brain
    Kanta Horie, Nicolas R. Barthélemy, Nipun Mallipeddi, Li, Yan, Erin E. Franklin, Richard J. Perrin, Randall John Bateman, Chihiro Sato · 2020 · Figshare
41. Additional file 6 of Tau protein profiling in tauopathies: a human brain study
    Juan Lantero‐Rodriguez, Elena Camporesi, Laia Montoliu‐Gaya, Gobom, Johan, Diana Piotrowska, Maria Olsson, Irena Matečko‐Burmann, Bruno Becker, Ann Brinkmalm, Björn M. Burmann et al. · 2024 · Figshare
42. Additional file 5 of Tau protein profiling in tauopathies: a human brain study
    Juan Lantero‐Rodriguez, Elena Camporesi, Laia Montoliu‐Gaya, Gobom, Johan, Diana Piotrowska, Maria Olsson, Irena Matečko‐Burmann, Bruno Becker, Ann Brinkmalm, Björn M. Burmann et al. · 2024 · Figshare
43. Additional file 1 of Dynamic changes of CSF sTREM2 in preclinical Alzheimer’s disease: the CABLE study
    Ma, Ling-Zhi, Tan, Lan, Bi, Yan-Lin, Shen, Xue-Ning, Xu, Wei, Ma, Ya-Hui, Li, Hong-Qi, Dong, Qiang, Yu, Jin-Tai · 2020 · Figshare
44. Additional file 1 of CSF tau368/total-tau ratio reflects cognitive performance and neocortical tau better compared to p-tau181 and p-tau217 in cognitively impaired individuals
    Joel Simrén, Wagner Scheeren Brum, Nicholas James Ashton, Andréa Lessa Benedet, Thomas K. Karikari, Hlin Kvartsberg, Emma Sjons, Firoza Zubeida Lussier, Mira Chamoun, Stevenson, Jenna et al. · 2023 · Figshare
45. Additional file 1 of Global neuropathologic severity of Alzheimer’s disease and locus coeruleus vulnerability influences plasma phosphorylated tau levels
    Murray, Melissa E., Christina M. Moloney, Naomi Kouri, Jeremy A. Syrjanen, Billie J. Matchett, Darren M. Rothberg, Jessica F. Tranovich, Tiffany N. Hicks Sirmans, Heather J. Wiste, Baayla D.C. Boon et al. · 2024 · Figshare
46. Additional file 1 of Characterization of Alzheimer’s tau biomarker discordance using plasma, CSF, and PET
    Yu Guo, Huang, Yu-Yuan, Shen, Xue-Ning, Chen, Shi-Dong, Hu, Hao, Wang, Zuo-Teng, Tan, Lan, Yu, Jin-Tai · 2021 · Figshare
47. Additional file 3 of Tau protein profiling in tauopathies: a human brain study
    Juan Lantero‐Rodriguez, Elena Camporesi, Laia Montoliu‐Gaya, Gobom, Johan, Diana Piotrowska, Maria Olsson, Irena Matečko‐Burmann, Bruno Becker, Ann Brinkmalm, Björn M. Burmann et al. · 2024 · Figshare
48. Additional file 2 of Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer’s disease and PET amyloid-positive patient identification
    Nicolas R. Barthélemy, Randall John Bateman, Christophe Hirtz, Philippe Marin, François Bécher, Chihiro Sato, Audrey Gabelle, Sylvain Lehmann · 2020 · Figshare
49. Additional file 1 of Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer’s disease and PET amyloid-positive patient identification
    Nicolas R. Barthélemy, Randall John Bateman, Christophe Hirtz, Philippe Marin, François Bécher, Chihiro Sato, Audrey Gabelle, Sylvain Lehmann · 2020 · Figshare
50. Additional file 8 of Tau protein profiling in tauopathies: a human brain study
    Juan Lantero‐Rodriguez, Elena Camporesi, Laia Montoliu‐Gaya, Gobom, Johan, Diana Piotrowska, Maria Olsson, Irena Matečko‐Burmann, Bruno Becker, Ann Brinkmalm, Björn M. Burmann et al. · 2024 · Figshare
51. Additional file 1 of Tau protein profiling in tauopathies: a human brain study
    Juan Lantero‐Rodriguez, Elena Camporesi, Laia Montoliu‐Gaya, Gobom, Johan, Diana Piotrowska, Maria Olsson, Irena Matečko‐Burmann, Bruno Becker, Ann Brinkmalm, Björn M. Burmann et al. · 2024 · Figshare
52. Additional file 1 of The relationship of insulin resistance and diabetes to tau PET SUVR in middle-aged to older adults
    Gilda E. Ennis, Tobey J. Betthauser, Rebecca L. Koscik, Nathaniel A. Chin, Christian, Bradley T., Asthana, Sanjay, Johnson, Sterling C., Barbara B. Bendlin · 2023 · Figshare
53. Additional file 7 of Tau protein profiling in tauopathies: a human brain study
    Juan Lantero‐Rodriguez, Elena Camporesi, Laia Montoliu‐Gaya, Gobom, Johan, Diana Piotrowska, Olsson, Maria, Irena Matečko‐Burmann, Bruno Becker, Ann Brinkmalm, Björn M. Burmann et al. · 2024 · Figshare
54. Additional file 2 of Tau protein profiling in tauopathies: a human brain study
    Juan Lantero‐Rodriguez, Elena Camporesi, Laia Montoliu‐Gaya, Gobom, Johan, Diana Piotrowska, Olsson, Maria, Irena Matečko‐Burmann, Bruno Becker, Ann Brinkmalm, Björn M. Burmann et al. · 2024 · Figshare
55. Additional file 2 of Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
    Pieter Jelle Visser, Lianne Maria Reus, Gobom, Johan, Iris E. Jansen, Ellen Dicks, Sven J. van der Lee, Tsolaki, Magda, Frans R.J. Verhey, Julius Popp, Martinez-Lage, Pablo et al. · 2022 · Figshare
56. Additional file 1 of Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias
    Claudia Cicognola, Oskar Hansson, Philip Scheltens, Hlin Kvartsberg, Henrik Zetterberg, Charlotte Elisabeth Teunissen, Kaj Blennow · 2021 · Figshare
57. Additional file 4 of Tau protein profiling in tauopathies: a human brain study
    Juan Lantero‐Rodriguez, Elena Camporesi, Laia Montoliu‐Gaya, Gobom, Johan, Diana Piotrowska, Olsson, Maria, Irena Matečko‐Burmann, Bruno Becker, Ann Brinkmalm, Björn M. Burmann et al. · 2024 · Figshare
58. Chronic methanol exposure induces cognitive impairment and Alzheimer's‐like pathology in rhesus monkeys
    Hongwei Li, Changhua Shi, Keya Li, Xinjing Fu, Ying Lyu, Yanfeng Xu, Yunlin Han, Wei Liang, Qin Chuan, Ling Zhang · 2026 · Animal Models and Experimental Medicine
59. Chemiluminescent Nanoflower with Inherent Oxygen Vacancies for Coreactant-Free and Label-Free Immunoassay of pTau181
    D D Li, Keying Zheng, Ruoxian Zhang, Linfeng Zhuo, Wei Nie, Mingyu Jia, Xi Wei, Hua Cui · 2026 · Analytical Chemistry
60. Prévention du phénomène de nucléation et de la propagation des tauopathies par immunothérapie passive utilisant un anticorps ciblant une région centrale de la protéine tau
    Marie Albert · 2018 · theses.fr (ABES)
61. La protéine prion cellulaire : rôles physiologiques et implications croisées dans les maladies neurodégénératives amyloïdes
    Vincent Baudouin · 2020 · theses.fr (ABES)
62. Détermination de l’heure du décès et de la vitalité des blessures cutanées par immunodosage de biomarqueurs protéiques
    Pierre‐Antoine Peyron · 2020 · theses.fr (ABES)
63. Étude du rôle de la microglie dans la propagation de la protéine Tau : mise en place de nouveaux modèles
    Charlotte Duwat · 2021 · theses.fr (ABES)
64. The Role of Tubulin Polyglutamylation in Controlling the Binding and Activity of Microtubule-Interacting Proteins
    Mariya Genova · 2023 · theses.fr (ABES)
65. The Role of Molecular Chaperones in Tau Proteostasis: Potential Therapeutic Opportunities in Tauopathies
    Aneta Grabinska-Rogala, Jason E. Gestwicki · 2026 · Topics in medicinal chemistry
66. Sistema glinfático cerebral: de las bases a su importancia en el paciente neurocrítico
    Raúl Carrillo Esper, Karen Itzel González Martínez, Roberto Emmanuel Islas Ávila, Daniel Palma Morales · 2026 · Medicina Crítica
67. The Effect of Metabolic Syndrome on Alzheimer’s Disease: Physical Activity as a Preventive and Therapeutic Measure
    Eleazar Ramírez Hernández, Citlalli Netzahualcoyotzi, Gabriela Hurtado‐Alvarado, José Luis Sánchez, Alí Pereyra, David Arredondo Zamarripa, Luis Fernando Hernández-Zimbrón, Dulce Papy-García, Jorge Guevara, Natalia Gutiérrez Ponce et al. · 2026 · Brain Sciences
68. Molecular and statistical weaknesses of the p-tau217/Aβ1−42 plasma ratio for alzheimer’s diagnosis
    Christian Griñán‐Ferré, Mercè Pallàs, Rafael Franco · 2026 · Journal of Molecular Medicine
69. Ordered waves in a memristive excitable media under asymmetrical diffusion
    Zixuan Zhang, Yitong Guo, Zhao Lei, C.-Y. Wang · 2026 · Cognitive Neurodynamics
70. Transient plasma p‐tau217 elevations after electroconvulsive therapy: A two‐case report
    Henri Hokkanen, Emilia Hintsala, Jaakko Hotta, Terhi Rantamäki-Häkkinen · 2026 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
71. Tau368 improves p-tau diagnostic accuracy for FTLD-tau from FTLD-TDP
    Przemysław Radosław Kac, Katheryn A Q Cousins, Alicja Szadziewska, Leslie M. J. Shaw, Michael Turton, Vivianna M. Van Deerlin, Peter Harrison, Henrik Zetterberg, David A. Wolk, Corey T. McMillan et al. · 2026 · Acta Neuropathologica
72. Predicting pattern and spread of brain atrophy and tau deposition in progressive supranuclear palsy
    Alma Ghirelli, Farwa Ali, Yehkyoung C. Stephens, Heather M. Clark, Julie A. G. Stierwalt, Mary M. Machulda, Federica Agosta, Massimo Filippi, Dennis W. Dickson, Val J. Lowe et al. · 2026 · NeuroImage Clinical
73. Brain organoids in Alzheimer disease and related tauopathies: Challenges and opportunities for translational readiness
    Anuj Guruacharya, Thomas Härtung, Roberta Souza dos Reis, Natália Chermont dos Santos Moreira, Liliana Attisano, Silvia Bolognin, Khalid Iqbal, Binita Rajbanshi · 2026 · Stem Cell Reports
74. A third-generation, high-affinity biparatopic anti-tau antibody inhibits intracellular tau aggregation seeded by Alzheimer’s brain extracts
    Eric Hatterer, Lucile Broyer, Sara Pecoraro, Fabien Cusin, Naz Simsek, John J. P. Brevé, Mathieu Clavel, Kevin Llewelyn Batenburg, Bart Klein, Thuur Zuidweg et al. · 2026 · Alzheimer s Research & Therapy
75. Altered olfactory adaptation of primary olfactory cortex-hippocampus-parietal lobe in Alzheimer’s disease continuum: An olfactory task fMRI study
    Xi Wu, Yajing Zhu, Shunshun Du, Qian Chen, Futao Chen, Xinru Xu, Cong Long, Danni Ge, Yan Lei, Yijun Bai et al. · 2026 · NeuroImage
76. T-2 toxin disrupts Alzheimer’s-relevant App/Tau homeostasis via circadian-p53-senescence crosstalk: Evidence from human neuroblastoma cells
    Tong Nie, Junyao Li, Shiqing Tan, Shixiang Chen, 杨德年, Eugenie Nepovimová, Qinghua Wu, Kamil Kuča · 2026 · NeuroToxicology
77. External Validation of a Mathematical Model of Brain Health
    Halima Sadia, Nicolas Doyon, Simon Duchesne, Alzheimer’s Disease Neuroimaging Initiative · 2026 · medRxiv
78. Tau-PET subtype modifies the association between plasma p-tau217 and memory in Alzheimer’s disease
    Lukai Zheng, Elham Ghanbarian, Carlos Albarrán Morillo, Kyan Younes, Crystal M. Glover, Laura A. Rabin, Joshua D. Grill, Michael Ewers, S. Ahmad Sajjadi, Ali Ezzati et al. · 2026 · medRxiv
79. Gantenerumab reduces brain amyloid-β proteoforms: Biochemical evaluation in dominantly inherited Alzheimer disease
    Soumya Mukherjee, Nicolas R. Barthélemy, Taraneh E Atri, Qing Wang, Daniel P. Yen, Yingxin He, Reid A. Coyle, Vitaliy Ovod, Erin E. Franklin, Chengjie Xiong et al. · 2026 · medRxiv
80. Quantitative Relationship Between Lumipulse G Measures of pTau217 in Plasma and the Temporal Cortex
    Steffi De Meyer, Sandra O. Tomé, Bas Lahaije, Jeroen Vanbrabant, Charlotte Lambrechts, Julie Goossens, Eugeen Vanmechelen, Kristel Sleegers, Christine A. F. Von Arnim, Thomas Tousseyn et al. · 2026 · Neurology
81. Current Biomarkers in Neurology: A Clinical Perspective
    Ozan Dörtkol, Zeynep Kara, Arife Çimen Atalar · 2026 · Acta Medica Alanya
82. Association Between Plasma N-Terminal Tau, Cognitive Decline, and Neurodegeneration in the ADNI Cohort
    Yiwen Rao, Lei Liu, Beth L. Ostaszewski, Amirah K. Anderson, Valentina Pinilla, Zahra Shirzadi, Era M. Laho, Andrew M. Stern, Wai‐Ying Wendy Yau, Hyun‐Sik Yang et al. · 2026 · Neurology
83. BindingDB Entry 50021669: Small molecules targeting molecular chaperones for tau regulation: Achievements and challenges.
    BindingDB · 2025 · UC San Diego
84. The Association of Amyloid‐β and Tau With Synaptic Dysfunction in Alzheimer's Disease
    Fausto Roveta, Augusto J. Mendes, Valentina Garibotto, Cecilia Boccalini, Aurélien Lathuilière, Innocenzo Rainero, Elisa RUBINO, Henrik Zetterberg, Nicholas James Ashton, Federica Ribaldi et al. · 2026 · Annals of Clinical and Translational Neurology